News

Non-Hodgkin Lymphoma

When 51-year-old father-of-two Rue Metha from Cheadle began experiencing what he thought was acid reflux, it was a serious illness. Unfortunately, his …

Ebola Outbreak Response

The Democratic Republic of Congo (DRC) has declared its 16th Ebola outbreak in Kasai Province, triggering a robust wave of global and …

Stolen Healthcare Data

Absolute Dental, a leading dental care provider in Nevada with over 50 locations, has confirmed that a cyberattack in February 2025 exposed …

Biomedical Supply Chain

Bio X Cell has appointed Cambridge Bioscience, a member of the Europa Biosite group, as its exclusive distributor for the region. This …

Australian Pneumococcal Vaccine

From September 1, 2025, Australian parents no longer have to worry about the high cost of protecting their children against pneumococcal disease. …

Seafood Safety

The U.S. Food and Drug Administration (FDA) has expanded its investigation after reports of radioactive contamination in shrimp imports, prompting multiple companies …

Thunderstorm Asthma Concerns

Doctors in Australia are warning that climate change is increasing thunderstorm asthma, a condition that strikes suddenly and affects not only asthma …

UV Ray Protec

Celebrity chef Gordon Ramsay recently revealed that he underwent surgery to remove a patch of skin cancer. Sharing his story publicly, Ramsay …

Gender Bias in Drug Trials

In a huge international study in cardiac care, researchers found that beta blockers, long considered an essential drug after a heart attack, …

Pediatric Brain Tumor Research

The National Cancer Institute (NCI) announced it would end support for the Pediatric Brain Tumor Consortium (PBTC), a research network that has …

New UTI Remedy

For the first time in three decades, the UK has approved a new antibiotic called Gepotidacin to treat urinary tract infections (UTIs). …

Weight Loss Pill

A new weight loss Pill called Orforglipron is making headlines for its promise to be cheaper and more convenient than injectable drugs …

Scroll to Top